A strategy for the development of two clinically active cisplatin analogs: CBDCA and CHIP. [electronic resource]
Producer: 19900423Description: 395-404 p. digitalISSN:- 0344-5704
- Animals
- Antineoplastic Agents -- pharmacology
- Carboplatin
- Chemical Phenomena
- Chemistry
- Cisplatin -- analogs & derivatives
- Drug Design
- Drug Evaluation
- Drug Screening Assays, Antitumor
- Humans
- Leukemia L1210 -- drug therapy
- Male
- Mice
- Neoplasms, Experimental -- drug therapy
- Organoplatinum Compounds -- adverse effects
- Rats
- Rats, Inbred F344
No physical items for this record
Publication Type: Comparative Study; Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.